Previcox

RSS

firocoxib

Authorised
This medicine is authorised for use in the European Union.

Overview

This is a summary of the European public assessment report (EPAR). Its purpose is to explain how the assessment done by the Committee for Medicinal Products for Veterinary Use (CVMP) on the basis of the documentation provided, led to the recommendations on the conditions of use.

This summary cannot replace a face-to-face discussion with your veterinarian. If you need more information about your animal’s medical condition or treatment, contact your veterinarian. If you want more information on the basis of the CVMP recommendations, read the scientific discussion (also part of the EPAR).

This EPAR was last updated on 28/04/2020

Authorisation details

Product details
Name
Previcox
Agency product number
EMEA/V/C/000082
Active substance
firocoxib
International non-proprietary name (INN) or common name
firocoxib
Species
Dogs
Anatomical therapeutic chemical veterinary (ATCvet) codes
QM01AH90
Publication details
Marketing-authorisation holder
Boehringer Ingelheim Vetmedica GmbH
Revision
23
Date of issue of marketing authorisation valid throughout the European Union
13/09/2004
Contact address

Binger Strasse 173
55216 Ingelheim am Rhein
Germany

Product information

17/04/2020 Previcox - EMEA/V/C/000082 - IB/0048/G

Other EU languages available icon This medicine’s product information is available in all official EU languages.
Select ‘available languages’ to access the language you need.

 

Product information documents contain:

  • summary of product characteristics (annex I);
  • manufacturing authorisation holder responsible for batch release (annex IIA);
  • conditions of the marketing authorisation (annex IIB);
  • labelling (annex IIIA);
  • package leaflet (annex IIIB).

You can find product information documents for centrally authorised human medicines on this website. For centrally authorised veterinary medicines authorised or updated from February 2022, see the Veterinary Medicines Information website.

Pharmacotherapeutic group

Anti-inflammatory and anti-rheumatic products, non-steroids

Therapeutic indication

Tablets

For the relief of pain and inflammation associated with osteoarthritis in dogs.

For the relief of postoperative pain and inflammation associated with soft-tissue, orthopaedic and dental surgery in dogs.

Oral paste

Alleviation of pain and inflammation associated with osteoarthritis and reduction of associated lameness in horses.

Assessment history

How useful was this page?

Add your rating